Jeffrey Paley

This profile gathers the share dealings of Jeffrey Paley across 3 companies, led by Journey Medical Corp, Avenue Therapeutics, Inc. and Travere Therapeutics, Inc. In total, 12 filings cover trades dated from 14 August 2014 to 28 November 2023.

Market trades split into 4 purchases (€195k) and 4 sales (€200k). The net balance comes to €5,128 on the selling side. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 3 share grants. So far in 2023, the count stands at 2 purchases and 3 sales.

In size, the median ticket on the buying side is €45k. 2 out of 4 purchases came within 30 days of a purchase by at least one other insider of the same company. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase. For 4 purchases whose 90-day window has closed, the share price was higher on day 90 than the day after publication in 100% of cases, with a median move of +54.3%. Past outcomes like these are no guarantee of what comes next.

The record was last updated on 8 December 2023 with an open-market sale (€896) in Journey Medical Corp. The most recent open-market purchase was published on 10 October 2023, 1,126 days ago. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.